LifeStance Health Group, Inc. Stockholders Equity

Quick Answer

LifeStance Health Group, Inc. reported Stockholders Equity of $1.52 billion for fiscal year 2025.

LifeStance Health Group, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $1.52B +5.2%
2024 $1.45B +1.2%
2023 $1.43B -5.9%
2022 $1.52B -1.7%
2021 $1.55B +54.8%
2020 $997.84M +314.9%
2020 -$464.38M
2020 $0.00 +100.0%
2019 -$166.35M -52.5%
2018 -$109.10M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $1.49B +3.9% +1.3%
June 30, 2025 $1.47B +3.1% +1.2%
March 31, 2025 $1.46B +2.0% +0.7%
December 31, 2024 $1.45B +1.2% +0.6%
September 30, 2024 $1.44B -1.2% +0.5%
June 30, 2024 $1.43B -4.3% +0.1%
March 31, 2024 $1.43B -5.1% +0.0%
December 31, 2023 $1.43B -5.9% -1.8%
  • LifeStance Health Group, Inc. showed an increase of +5.2% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2018–2025 period, LifeStance Health Group, Inc.’s stockholders equity has grown by 1494.1% (from -$109.10 million to $1.52 billion).
  • The most recent figure is from LifeStance Health Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment